Therapeutic Options for Visceral Leishmaniasis

Visceral leishmaniasis (VL), also known as Kala-Azar, is a disseminated protozoal infection caused principally by Leishmania donovani and Leishmania infantum (known as Leishmania chagasi in South America). The therapeutic options for VL are diverse and depend on different factors, such as the geogra...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs (New York, N.Y.) N.Y.), 2013-11, Vol.73 (17), p.1863-1888
Hauptverfasser:	Monge-Maillo, Begoña, López-Vélez, Rogelio
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiprotozoal Agents - therapeutic use Biological and medical sciences Clinical trials Drug Resistance Drugs HIV Infections - complications Human immunodeficiency virus Human protozoal diseases Humans Infections Infectious diseases Internal Medicine Leishmania chagasi Leishmania donovani Leishmania donovani - isolation & purification Leishmania infantum Leishmania infantum - isolation & purification Leishmaniasis, Visceral - drug therapy Leishmaniasis, Visceral - epidemiology Leishmaniasis, Visceral - parasitology Leshmaniasis Malnutrition Malnutrition - complications Medical sciences Medicine Medicine & Public Health Parasitic diseases Pharmacology/Toxicology Pharmacotherapy Protozoa Protozoal diseases Review Review Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!